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Porcine heart was observed to express annexins V (CaBP33) and VI in large amounts, and annexins III and IV in much smaller amounts. Annexin 
V (CaBP33) in porcine heart was examined in detail by immunochemistry. Homogenization and further processing of heart in the presence of 
EGTA resulted in the recovery of annexin V (CaBP33) in the cytosolic fraction and in an EGTA-resistant, Triton X-IOO-soluble fraction from 
2+ cardiac membranes. Including Ca in the homogenization medium resulted in a significant decrease in the annexin V (CaBP33) content of the 
cytosolic fraction with concomitant increase in the content of this protein in myofibrils, mitochrondria, the sarcoplasmic reticulum and the sarcolem- 
ma. The amount of annexin V (CaBP33) in each of these subfractions depended on the free Ca*+ concentration in the homogenizing medium. 
At the lowest free Ca2+ concentration tested, 0.8 PM, only the sarcolemma appeared to contain bound annexin V (CaBP33). Membrane-bound 
annexins V (CaBP33) and VI partitioned in two fractions, one EGTA-resistant and Triton X-IOO-extractable, and one Triton X-loo-resistant and 
EGTA-extractable. Altogether, these data suggest that annexins V and VI are involved in the regulation of membrane-related processes. 
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1. INTRODUCTION 
Annexins, also known as lipocortins, constitute a 
novel family of intracellular Ca’ + -binding proteins 
sharing the ability to bind to acidic phospholipids and 
biological membranes in a Ca’ + -dependent way (for 
reviews see [l-3]). Two acidic Ca2+ -binding proteins, 
CaBP33 and CaBP37, originally purified from bovine 
brain by Ca2 + -dependent affinity chromatography [4] 
were shown to be annexins on the basis of their ability 
to bind to acidic phospholipids and brain membranes in 
the presence of Ca2+ [5]. A substantial fraction of the 
CaBP33/CaBP37 mixture bound to membranes was 
resistant o Triton X-100, in the presence of Ca2+, and 
extractable with EGTA from the Triton X-lOO-resistant 
residue [5], suggesting an association of these two pro- 
teins with the cytoskeleton in the brain. Actually, the 
CaBP331CaBP37 mixture was shown to bind saturably, 
reversibly and with a relatively high affinity to a 
cytoskeleton preparation obtained from brain mem- 
branes, particularly to a set of low M, polypeptides pre- 
sent in the cytoskeleton preparation [6]. Rat brain turn- 
ed out to express only CaBP33 [5]. While two proteins 
comigrating with CaBP33 and CaBP37, respectively, in 
SDS gels were purified from porcine heart by 
Ca2 + -dependent affinity chromatography, only the 
lower h4, species (CaBP33) was recognized in Western 
blots by a polyclonal antiserum raised against the un- 
fractionated bovine brain CaBP33/CaBP37 mixture 
[5]. Also, the yield of the putative porcine heart 
CaBP37 was extremely low. 
Concomitantly with our observation that CaBP33 
and CaBP37 were brain annexins, Woolgar et al. [7] 
demonstrated that three annexins could be isolated 
from porcine brain, a 68 kDa annexin homologous to 
the 68 kDa annexin (annexin VI) found in liver, adrenal 
medulla, and lymphocytes, endonexin I (annexin IV), 
and a 32 kDa annexin homologous to human placental 
endonexin II (annexin V). These homologies were 
established by an immunochemical approach using an- 
tisera raised against liver 68 kDa annexin, endonexin I
from adrenal medulla, and placental endonexin II [7]. 
Amino acid sequence analysis of CaBP33 (manuscript 
in preparation) demonstrated that this protein was 
highly homologous to endonexin II (annexin V) [8], 
suggesting that CaBP33 could be the brain (iso)form of 
endonexin II (annexin V). The identity of CaBP37 re- 
mains to be elucidated. 
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We sought to have more detailed information on car- 
diac annexins, with special reference to annexin V 
(CaBP33). Our results indicate that the mammalian 
heart expresses everal annexins, among which the most 
prominent species are CaBP33 (annexin V), and a 70 
kDa protein (annexin VI). Subcellular fractionation 
studies indicate that myofibrils, mitochondria, the sar- 
coplasmic reticulum (SR) and the sarcolemma (SL) all 
have annexin V (CaBP33) bound, provided Ca2+ has 
been included in the homogenization buffer, and that 
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the free Ca2 + concentration during tissue homogeniza- 
tion and subsequent steps dictates the amounts of an- 
nexin V (CaBP33) recovered in any of the above sub- 
fractions. Evidence will also be presented indicating 
that, once bound to cardiac membranes in the presence 
of Ca2 + , annexin V (CaBP33) and annexin VI partition 
in two parts, one resistant to EGTA and extractable 
with Triton X-100, and one resistant o Triton X-100 
and extractable with EGTA. 
2. MATERIALS AND METHODS 
2.1. Isolation of cardiac annexins 
To identify as many annexins as possible in porcine heart, the pro- 
cedure described by Boustead et al. [9] was used with minor changes. 
All operations were done at 4°C. The EGTA-solubilized proteins [9] 
were loaded onto a column (1 x 10 cm) of DEAE Sephacel 
equilibrated with 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 5 mM 
2-mercaptoethanol (buffer A). The column was washed with 100 ml 
of buffer A and eluted with increasing concentrations of NaCl in buf- 
fer A (50 ml/step). Individual protein peaks as well as the unfrac- 
tionated EGTA extract and proteins not retained by the resin were 
analyzed by SDS-PAGE [lo] and immunoblotting [l I] using a rabbit 
antiserum raised against the unfractionated bovine brain 
CaBP33/CaBP37 mixture [5]. The protein peak from the DEAE 
Sephacel column (protein peak II) containing polypeptides of 33 and 
70 kDa in large amounts (see Results) was concentrated by pressure 
dialysis and gel filtered through Sephacryl S-200 (2 x 90 cm) in buffer 
A to achieve final purification of the above polypeptides. Protein 
peak III (see results) was similarly treated to purify a 70 kDa doublet 
therein. The other protein peaks from the DEAE Sephacel column 
were concentrated likewise and not further fractionated. All protein 
samples were dialysed against deionized, double-distilled water and 
lyophilized. 
2.2. Binding of cardiac annexins to phospholipids 
Individual pure proteins and protein fractions from the DEAE 
Sephacel column containing heterogeneous populations of proteins 
were assayed for their ability to bind to liposomes of different 
phospholipid composition as described [9]. Briefly, proteins were in- 
cubated at room temperature in 0.5 ml of 20 mM Tris-HCl, pH 7.5, 
0.1 M KCI, 2 mM MgC12, 1 mM EGTA containing liposomes of either 
phosphatidylcholine (PC) or cardiolipin (CL) (150 pg each) in the 
absence and presence of 100 pM free Ca* + . After 20 min, the suspen- 
sions were centrifuged at 12 000 x g for 10 min, and the supernatants 
were saved. Individual pellets were resuspended in 0.5 ml of the ap- 
propriate incubation buffer and centrifuged as above. This operation 
was repeated once more. Individual final pellets were resuspended in 
0.5 ml of 20 mM Tris-HCl, pH 7.5, 5 mM EGTA. Equal volumes of 
supernatants and pellets were subjected to SDS-PAGE. Liposomes 
were obtained as previously described [ 121. 
2.3. Distribution of annexins V (CaBP33) and VI in cardiac 
subfractions 
Aliquots (10 g) of porcine heart tissue were homogenized in 50 ml 
of 20 mM Tris-HCl, pH 7.5, 0.1 M KCI, 1 mM MgCl2, 0.25 mM 
PMSF, containing 5 mM EGTA (buffer E), no other additions (buffer 
B), or 1 mM CaC12 (buffer C). Homogenates were filtered through 
cheese-cloth and centrifuged at 750 x g for 8 min. The supernatants 
(S,) were saved. The upper layers of individual pellets containing 
myofibrils (131 were washed 5 more times in the respective buffers by 
cycles of resuspension and centrifugation. Individual final pellets 
were resuspended in buffer E and centrifuged at 150 OOOxg for 30 
min to obtain three EGTA-extracts from myofibrils. The SI super- 
natants were centrifuged at 60 000 x g for 20 min to obtain PZ pellets 
that were resuspended in the respective buffers and centrifuged again. 
The resultant supernatants were centrifuged at 150 000 x g for 60 min 
54 
to yield the cytosolic fractions (SZ). The PZ pellets containing 
mitochondria plus cardiac microsomes (141 were resuspended in the 
respective buffers minus KC1 and centrifuged. This operation was 
repeated two more times before extraction of individual PZ pellets 
with 1% (w/v) Triton X-100 in buffers E, B, and C minus KC], 
respectively. After 15 min, the suspensions were centrifuged at 
150 OOOxg for 90 min to obtain three Triton X-lOO-extracts. The 
resultant pellets containing the Triton X-lOO-unsoluble materials were 
washed 3 times in buffers E, B, and C minus KCI, respectively, by 
cycles of resuspension and centrifugation. Individual final pellets 
were resuspended in 20 mM Tris-HCI, pH 7.5,5 mM EGTA, and cen- 
trifuged to obtain three EGTA-extracts. Individual Sz supernatants 
and Triton X-lOO-extracts were brought to 60% saturation with solid 
(NHd)zSOd and centrifuged. The supernatants were brought to 80% 
saturation with (NH&S04 and centrifuged. Individual pellets were 
resuspended in buffer A and dialyzed against the same buffer. All 
operations were done at 4°C. All soluble and solubilized fractions 
were subjected to SDS-PAGE and immunoblotting as mentioned in 
the preceding section. 
Fractionation of the post-myofibril supernatant from porcine heart 
to obtain the SL and SR fractions was done following the methods of 
Suko and Hasselbach [14] and Tuana et al. [15] with minor changes. 
The mitochondrial and SRI pellets [14], and the SL and SRI pellets 
[15] were washed 3 times in the separation buffer minus sucrose (20 
mM Tris-HCl, pH 7.5, 1 mM MgC12, 0.25 mM PMSF, plus or minus 
CaClz as required) by cycles of resuspension and centrifugation 
before extraction with 20 mM Tris-HCI, pH 7.5, 5 mM EGTA. All 
operations were done at 4°C. The extracts were subjected to SDS- 
PAGE and immunoblotting as above. 
2.4. Purification of the CaBP33KaBP37 mixture, annexin V 
(CaBP33) and annexin VI from bovine brain 
The CaBP33/CaBP37 mixture was purified as in [4]. The two pro- 
teins were separated from one another as in [5]. Annexin VI was 
purified as in [7]. 
3. RESULTS AND DISCUSSION 
Subjecting the Ca2+ -precipitated, EGTA-extractable 
proteins obtained from heart tissue to DEAE 
chromatography resulted in the separation of four pro- 
tein peaks (Fig. 1A). Peaks I and IV contained 
heterogeneous populations of polypeptides (Fig. 1B) 
and were not further fractionated. Peak II contained 
polypeptides of 70 and 33 kDa in large amounts plus 
minor contaminants (Fig. 1B). Close inspection of gels 
revealed that the 70 kDa polypeptide was a doublet 
(also see Fig. 2B). Protein peak II was subjected to gel 
filtration to obtain pure 70 and 33 kDa proteins (Fig. 2). 
The 70 kDa doublet comigrated in SDS gels with bovine 
brain annexin VI (Fig. 1B). The 33 kDa protein com- 
igrated in SDS gels with bovine brain annexin V 
(CaBP33) (Fig. 1B) and was recognized by the an- 
tiserum raised against the bovine brain 
CaBP33/CaBP37 mixture in Western blots (Figs 1B 
and 2A), suggesting that the 33 kDa protein was authen- 
tic annexin V (CaBP33). The possibility that the 33 kDa 
protein in DEAE protein peak II might be annexins 111 
or IV was excluded since: (i) the antiserum against the 
CaBP33/CaBP37 mixture as well as the anti-brain an- 
nexin V (CaBP33) antiserum recognized by im- 
munoblotting a 33 kDa polypeptide in EGTA-extracts 
from skeletal muscles that has been reported not to con- 
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Fig. 1. Isolation of porcine heart annexins. (A) DEAE Sephacel chromatography of Ca2+ -precipitated, EGTA-extractable proteins. These were 
loaded onto a column of DEAE Sephacel and eluted with increasing concentrations of NaCl as indicated. Fractions of 2.5 ml were collected and 
monitored for protein content. (Asso). (B) SDS-PAGE (lanes l-7) and immunoblotting (lanes S-14) of (1,8) annexin V (CaBP33) plus annexin VI 
from bovine brain, (2.9) the material oaded onto the column, (3,lO) the material unretained by the resin, (4,11) protein peak I, (5,12) protein peak 
II, (6,13) protein peak III, and (7,14) protein peak IV. Immunoblotting was done using the antiserum against he bovine brain CaBP33KaBP37 
mixture [5]. Identical results were obtained with the anti-bovine brain annexin V (CaBP33) antiserum. The arrow and arrowhead point to the posi- 
tions of annexins V (CaBP33) and VI, respectively. 10% acrylamide gels were used in these as well as in experiments illustrated in Figs 2-7. Gels 
were stained with Coomassie blue. 
tain annexin IV [16]; and (ii) annexins III and IV bound 
to DEAE resins are eluted with 0.01 M NaCl [16], 
whereas annexin V and bovine brain annexin V require 
0.15-0.20 M NaCl for elution from similar resins 
([5,18] and Fig. 1A). Moreover, PAGE under non- 
denaturing conditions showed that porcine heart an- 
nexin V (CaBP33) comigrated with the slow migrating 
band of the bovine brain CaBP33/CaBP37 mixture, 
with no additional bands (not shown). As to the DEAE 
protein peak III (Fig. lA), this also was processed by 
Sephacryl chromatography (not shown) to obtain a 70 
kDa polypeptide in pure form (cf. Fig. 3C). 
Porcine heart annexin V (CaBP33) bound in the 
presence, but not in the absence, of 100 pM free Ca*+ 
to the negatively charged phospholipid, cardiolipin 
(CL) (Fig. 3A). This binding was completely reversed 
by EGTA, as judged by SDS-PAGE (Fig. 3A). No bin- 
ding of annexin V (CaBP33) to liposomes of 
phosphatitylcholine (PC) was observed, irrespective of 
Fig. 2. Purification of porcine heart annexin V (CaBP33) and annexin 
VI (the 70 kDa doublet in DEAE protein peak II). (A) SDS-PAGE 
(lanes 1.2) and immunoblotting (lanes 3,4) of (I ,3) porcine heart an- 
nexin V (CaBP33) and (2,4) bovine brain annexin V (CaBP33). (B) 
SDS-PAGE (lane 1) and immunoblotting (lane 2) of porcine heart an- 
nexin VI. Immunoblotting was done as described in Fig. IB. Note that 
the antisera do not cross-react with annexin VI. 
the presence or absence of Ca*+ (Fig. 3A). As to the 70 
kDa doublet obtained from DEAE protein peak II, on- 
ly the higher M, species appeared to behave as an annex- 
in, in that it bound to CL, but not to PC, vesicles in the 
presence of Ca* + , although a certain amount of this 
protein co-sedimented with CL and PC liposomes even 
in the absence of Ca*+ (Fig. 3B). Most of the polypep- 
tides in DEAE protein peaks I and IV sedimented with 
CL vesicles (Fig. 3D) and with PC vesicles (not shown) 
independently of Ca* + , with the exception of a 33 kDa 
polypeptide in protein peak I which sedimented with 
CL, but not PC, vesicles Ca* + -dependently (not 
shown). This 33 kDa polypeptide probably was a mix- 
ture of annexins III and IV [16] since it was detached 
from the DEAE column at 0.1 M NaCl (Fig. 1A). The 
70 kDa doublet purified from DEAE protein peak III 
also was tested in the liposome binding assay (Fig. 3C). 
Of the two polypeptides, only the lower M, species, that 
was the most abundant, sedimented with CL vesicles in 
the presence, but not in the absence, of Ca*+ . No bin- 
ding of this polypeptide to PC vesicles was observed 
(not shown). At present we do not know whether the 
higher M, species in the 70 kDa doublet from DEAE 
peak II and the lower A4, species in the 70 kDa doublet 
in DEAE peak III are identical or related proteins. 
It is generally accepted that membrane-associated an- 
nexins resist extraction with Triton X-100, albeit in the 
presence of Ca* + , and bind to cytoskeleton elements in 
aCa*+ -dependent way [5,6,17-211. However, annexins 
I and II, and the CaBP33/CaBP37 mixture from bovine 
brain have been shown to exist in a membrane-bound 
form that is resistant o EGTA and is solubilized with 
Triton X-100 [5,22-241. To monitor the distribution of 
annexins V (CaBP33) and VI in porcine heart, in a first 
series of experiments three subfractions, i.e. the 
cytosol, myofibrils, and a post-myofibril membrane 
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Fig. 3. Binding of cardiac annexins to phospholipids. (A) Binding of 
porcine heart annexin V (CaBP33) to liposomes of PC (lanes 1-4) and 
CL (lanes 5-10). Identical samples of supernatants (s) and pellets (p) 
obtained after centrifugation of suspensions of liposomes previously 
incubated with 30 pg of annexin V (CaBP33)/ml in the absence (lanes 
1,2,5,6) and presence (lanes 3,4,7,8) of 100 PM free Ca*+ were sub- 
jected to SDS-PAGE. No binding of annexin V (CaBP33) to PC 
liposomes occurs irrespective of the absence or presence of Ca*+, 
whereas Ca*+-dependent binding of the protein to CL liposomes is 
observed. Lanes 9, 10 refer to an experiment in which the protein was 
incubated with CL vesicles in the presence of 100 PM free Ca’+ for 
20 min before addition of EGTA to 1 mM EGTA completely reverses 
the Cazi-dependent binding of the protein to CL vesicles. (B) Binding 
of porcine heart annexin VI (purified from DEAE protein peak II) to 
liposomes of PC (lanes 1-4) and CL (lanes 5-10). Conditions were as 
described in (A). Only the higher M, species of the doublet behaves in 
part as an annexin. (C) Binding of the 70 kDa doublet purified from 
DEAE protein peak III to liposomes of CL. Conditions were as 
described in A in the absence (lanes 1,2) and presence (lanes 3,4) of 
100 FM fre Ca”. Only the lower M, species of the doublet behaves 
as an annexin. (D) Binding of proteins from DEAE protein peak IV 
to CL vesicles. Conditions were as described in (A) in the absence 
(lanes 1,2) and presence (lanes 3,4) of 100 pM free Ca’+ , except that 
120 pg of the protein mixture/ml were used. None of the polypeptides 
in this protein mixture behaves as an annexin. 
fraction containing mitochondria, the SR and the SL, 
were analyzed. As the total CaCl* concentration in the 
homogenizing medium increased from 0 to 1 mM, the 
amount of annexin V (CaBP33) in the cytosolic fraction 
decreased, judging from immunoblot analyses (not 
shown), whereas it concomitantly increased in 
myofibrils (not shown) and in the Triton 
X-lOO-resistant residue from membranes (Fig. 4). No 
appreciable changes in the annexin V (CaBP33) content 
were observed in the Triton X-LOO-soluble fractions 
from membranes (not shown). Thus the increase in the 
1234 5678 
Fig. 4. Annexins V (CaBP33) and VI in the EGTA-extracts from post- 
myofibril membranes previously solubilized with Triton X-100. 
(Lanes 1-4) SDS-PAGE of (1) annexins V (CaBP33) and VI from por- 
cine heart, (2-4) the EGTA-extracts from membranes prepared in the 
presence of EGTA, with no additions, or in the presence of Ca’+ , 
respectively. (Lanes 5-8) The same materials as in lanes l-4 were sub- 
jected to immunoblotting as described in Fig. 1B. Note that large 
amounts of annexins V (CaBP33) and VI are found exclusively in the 
EGTA-extract from membranes prepared in the presence of Ca* + . 
The arrow and arrowhead point to the position of annexins V 
(CaBP33) and VI, respectively. 
annexin V (CaBP33) content of myofibrils and the 
Triton X-lOO-resistant residue had occurred at the ex- 
pense of the cytosolic annexin V (CaBP33). Since a 
substantial amount of the protein was recovered in the 
Triton X-lOO-extract from membranes obtained in the 
presence of EGTA, we concluded that this fraction of 
annexin V (CaBP33) was tightly bound to membranes. 
We also performed experiments in which membranes 
prepared in the presence of either 5 mM EGTA or 1 mM 
CaClz were first extracted with EGTA, then washed 4 
times in EGTA, and finally extracted with Triton 
X-100. Virtually no annexin V (CaBP33) was recovered 
in the EGTA-extract from membranes prepared in 
EGTA, whereas a large amount of it was recovered in 
the EGTA-extract from membranes prepared in CaC12, 
1234 5 678 9 10 
Fig. 5. Annexin V (CaBP33) and EGTA- and Triton X-100.extracts 
from cardiac membranes. These were prepared in the presence of 
EGTA (lanes 2,4,7,9) and in the presence of Ca* + (lanes 3,5,8,10) and 
first extracted with EGTA (lanes 2,3,7,8) and then with Triton X-100 
(lanes 4,5,9,10) as described in the text. Lanes 1,5 contain annexins V 
(CaBP33) and VI purified from bovine brain. SDS-PAGE and im- 
munoblotting were done as described in Fig. IB (lanes I-5 and lanes 
6-10, respectively). Note that annexin V (CaBP33) is found in the 
EGTA-extract from membranes obtained in the presence, but not in 
the absence, of Cal+, and that both Triton X-lOO-extracts contain ap- 
preciable amounts of the protein. The arrow and arrowhead point to 
the positions of bovine brain annexins V (CaBP33) and VI, respec- 
tively. 
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as expected (Fig. 5). On the other hand, the amounts of 
annexin V (CaBP33) in the two Triton X-lOO-extracts 
were simular or the amount of Triton X-lOO-soluble an- 
nexin V (CaBP33) in the Triton X-lOO-extract from 
membranes prepared in CaCl2 was larger than that 
from membranes prepared in EGTA (Fig. 5). These 
data suggested that: (i) annexin V (CaBP33) was induc- 
ed to bind to cardiac membranes by Ca2 + ; (ii) 
membrane-bound annexin V (CaBP33) partitioned in 
two fractions, one dissociable by EGTA and tentatively 
considered bound to the polar surface of the membrane 
lipid bilayer and/or to cytoskeleton elements, and one 
undissociable by EGTA and extractable with Triton 
X-100; and (iii) Ca2+ caused annexin V (CaBP33) to 
bind tightly to the lipid bilayer and/or to one or more 
membrane intrinsic proteins, but once bound to these 
targets the protein no longer required Ca2 + for it to re- 
main bound to membranes. If these conclusions are 
correct, then the Triton X-lOO-soluble annexin V 
(CaBP33) obtained from membranes prepared in 
EGTA resulted from Ca2 + -dependent binding of the 
protein to membranes in vivo. The 70 kDa polypeptide 
comigrating with bovine brain annexin VI in SDS gels 
appeared to behave similarly to annexin V (CaBP33) 
(Figs 4 and 5). 
Next we examined the distribution of the 
Ca2 + -dependently bound annexin V (CaBP33) in car- 
diac membrane subfractions. To this end, mitochon- 
dria, the SR and the SL were purified in the presence of 
1 mM Ca2+. Individual EGTA-extracts from these 
membranes were subjected to SDS-PAGE and im- 
munoblotting using the anti_CaBP33/CaBP37 an- 
tiserum. Annexin V (CaBP33) was recovered in all 
EGTA-extracts (Fig. 6). Again, the 70 kDa polypeptide 
(annexin VI) was likewise detected (Fig. 6). When the 
above membrane subfractions were prepared in the 
presence of increasing free Ca2 + concentrations (Fig. 
7), annexin V (CaBP33) was detected in the SL starting 
from 0.8 PM free Ca2 + , in the SR starting from 100 pM 
free Ca2 + , and in mitochondria starting from 2 PM free 
Ca2+. These data suggested that the SL and, possibly, 
mitochondria, but not the SR, could be targets of an- 
nexin V (CaBP33) at physiological free Ca2+ concen- 
trations. 
Previous reports have shown that the mammalian 
heart expresses everal annexins including annexins III, 
IV, V, and VI [5,16,25,26]. In all these cases, identifica- 
tion of annexins was done by an immunochemical ap- 
proach using antisera raised against antigens from other 
tissues. In the present report, we looked for cardiac an- 
nexins by applying to porcine heart the so-called 
Ca2+ -precipitation method (91. Large amounts of an- 
nexin V (CaBP33), appreciable amounts of annexin VI, 
and relatively low amounts of annexins III and IV could 
be purified from this organ. Annexins I and II have 
been reported to be present in extremely low amounts in 
the heart [l-3]. Since at concentrations as low as 
0.8-2.0 PM free Ca2+ annexin V (CaBP33) was 
detected in the EGTA-extracts from the SL and 
mitochondria, whereas only at 100 FM free Ca2 + could 
the protein be seen in the EGTA-extract from the SR, 
recovery of annexin V (CaBP33) in cardiac subcellular 
fractions can be reasonably attributed to 
Ca2 + -dependent binding of annexin V (CaBP33) to 
these membranes, rather than to Ca2 + -induced 
precipitation. On the other hand, artifactual redistribu- 
A 
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123456 
1 2 3 4 5 6 7 8 9 IO 1112 Fig. 7. Distribution of annexin V (CaBP33) in the sarcolemma (A), 
the sarcoplasmic reticulum (B), and mitochondria (C) as a function of 
Fig. 6. Detection of annexins V (CaBP33) and VI in cardiac mem- free Ca” concentration. The three membrane subfractions were 
brane subfractions obtained in the presence of Ca”. Mitochondria, 
SL, SRI, and SRz (see section 2.3) were obtained in the presence of 1 
purified in the presence of 0 (lane 1). 0.8 (lane 2), 2 (lane 3), 11 (lane 
mM CaCb and extracted with EGTA. (Lanes l-6) SDS-PAGE of 
4). 50 (lane 5), and 100 (lane 6) pM free Ca*+ . After separation, in- 
(l-4) EGTA-extracts from mitochondria, SL, SRI, and SRr, respec- 
dividual subfractions were extracted with EGTA and centrifuged to 
tively, (5) the bovine brain CaBP33KaBP37 mixture, and (6) annex- 
obtain the EGTA-extracts. These were subjected to SDS-PAGE (not 
ins V (CaBP33) and VI from bovine brain. (Lanes 7-12) The same 
shown) and immunoblotting as described in Fig. 1B. Note that no an- 
nexin V (CaBP33) is found in the absence of Ca* + , that at concentra- 
protein fractions as in lanes l-6 were subjected to immunoblotting as tions as low as 0.8 pM free Ca’+ the protein is found in the sarcolem- 
described in Fig. 1B. The arrow and arrowhead point to the positions 
of annexins V (CaBP33) and VI, respectively. 
ma, and that the protein is found in the sarcoplasmic reticulum only 
at > 100 pM free Ca’+ 
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tion of this protein during tissue homogenization 
because of the presence of Ca’+ should be considered. 
Immunocytochemical analyses of the protein in cardiac 
tissue and in cultured cardiomyocytes will hefp 
elucidate this point. 
The finding that several annexins, including annexins 
V (CaBP33) and VI are recovered in EGTA-resistant, 
Triton X-100 soluble fractions from membranes con- 
trasts with the observation that annexins that have 
bound to phospholipids in the presence of Ca2 + come 
again in solution on addition of EGTA. Clearly, 
liposomes are not directly comparable with natural 
membranes. Membrane proteins could have an impor- 
tant role in defining the binding properties of annexins 
and in conditioning the structural features of 
membrane-bound annexins. Tight binding of annexins 
to natural membranes could imply partial penetration 
of these proteins into the lipid bilayer. In a recent report 
[27], this possibility has been excluded for a number of 
annexins as far as artificial membranes are concerned. 
However, data have been presented showing that 
human placental microvillar annexins, that had bound 
to CL or phosphatidylinositol vesicles in the presence of 
Ca*+, necessitate Triton X-100 for their complete 
solubilization [28]. Studies on natural membranes 
targeted with appropriate probes would help elucidate 
this issue. The functional meaning of membrane-bound 
annexins V (CaBP33) and VI remains to be determined, 
but it appears to be in line with the proposed role of an- 
nexins in the regulation of the structural organization 
of membranes in relation to both exocytosis and en- 
docytosis (31, also taking into consideration that the 
CaBP33fCaBP37 mixture from bovine brain interacts 
with a number of polypeptides in cytoskeletons from 
brain membranes [6]. As annexin V has been reported 
to be secreted (see [3]), it is possible that the fraction of 
membrane-associated annexin V (CaBP33) that is resis- 
tant to EGTA might be in transit toward the ex- 
tracellular space. Alternatively, this fraction of the pro- 
tein might be linked to membrane intrinsic proteins to 
regulate their functions. 
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